SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to a sharp pullback following the announcement of a 75-million share offering intended to fund capital contributions for its Georgia facility, which has overshadowed positive Q2 revenue guidance. Community sentiment is deeply divided between long-term investors who view the dilution as a necessary strategic move to unlock federal loan funding and retail traders expressing frustration over the timing and perceived impact on short-term price momentum.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is in the spotlight as investors debate the company's aggressive infrastructure spending and pivot toward monetizing excess AI compute capacity through potential cloud offerings. Community sentiment is deeply divided, with bulls pointing to the long-term value of Metas data center investments and potential AI model breakthroughs, while bears focus on capex concerns and increasing regulatory and legal pressures.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon Inc. (GRPN) is trending as investors discuss a potential structural short squeeze driven by a tight float, index inclusion, and active share buybacks. The community is highlighting a 'boxed' short position where the combination of institutional ownership and management's capital allocation leaves few shares available for shorts to cover, drawing frequent comparisons to past parabolic squeeze setups.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant community focus fueled by its high short interest, which traders are eyeing as a catalyst for a potential squeeze. Discussion is polarized between bullish participants highlighting the company's AI-focused partnerships and technical setup, and skeptics who remain wary of persistent price volatility and the lack of a clear, immediate move to the upside.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is experiencing intense community focus as traders debate the company's recent reverse stock split proposal, its aggressive Bitcoin accumulation strategy, and persistent volatility linked to its association with the Trump family. Investors are divided between those betting on significant upside potential driven by rising Bitcoin prices and legislative optimism, and others warning of ongoing dilution, management concerns, and structural risks.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently seeing significant investor focus following the appointment of Kathleen Tregoning, a veteran executive with a track record of guiding biotechs toward major acquisitions, to its board. The community is actively discussing the company's strong cash position, the upcoming Phase 3 durability data, and its potential as a first-mover in the treatment-resistant depression market as it advances toward an anticipated commercial launch.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending as investors react to a combination of high short interest and speculative momentum, fueled by anticipation of commercial milestones in the drone, smart eyewear, and AI device sectors. Community discussion remains polarized, with bulls tracking manufacturing progress and potential partnerships while bears highlight ongoing execution risks and historical price volatility.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the FDAs accelerated approval of its IgA nephropathy treatment, Trutakna, which marks a significant commercial milestone for the company. Community discussion is focused on the drug's broad label, the potential for rapid commercial uptake, and the possibility of future M&A interest as investors weigh the stock's performance against the broader competitive landscape in the rare kidney disease sector.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending as it navigates a major strategic shift toward an agentic AI-first operating model, recently headlined by a 20% workforce reduction that has sparked intense debate over the company's long-term profitability and AI monetization strategy. The community is actively dissecting the stock's volatile price action, weighing strong revenue growth and infrastructure dominance against concerns over premium valuation, margin pressure, and the operational impact of these significant staff cuts.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is currently the focus of significant market attention following a definitive $10 billion acquisition agreement by Vertex Pharmaceuticals at $85 per share in cash. Community members are actively debating the high premium, the strategic expansion into rare endocrine diseases, and the potential for rotation into other biotech merger candidates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 26th Annual New Ideas Summer Conference

UFP Technologies, Inc. (Nasdaq: UFPT), today announced that Mitchell Rock, President and Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will present and host 1x1 meetings at the CJS Securities 26th Annual New Ideas Summer Conference on...

UFP Technologies Director Sells $287,000 After Option Exercise as Shares Stay Flat

Key PointsA director of UFP Technologies sold 1,200 shares for approximately $287,000 on June 12, 2026, via an option exercise and immediate disposition at around $239.29 per share...

UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY

UFP Technologies, Inc. (Nasdaq: UFPT), today announced that Mitchell Rock, Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will present at the East Coast IDEAS Investor Conference on Wednesday, June 10, 2026 at The Westin Times Square in New...

UFP Technologies Names Ryan Stafford General Counsel and Senior Vice President of Human Resources

UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization specializing in single-use and single-patient medical devices, today announced the appointment of Ryan Stafford as General Counsel and Senior Vice President of Human Resources, effective June 4, 2026...

UFP Technologies (NASDAQ:UFPT) Sets New 52-Week Low  - Here's Why

UFP Technologies (NASDAQ:UFPT) Reaches New 12-Month Low - Here's Why...

UFP Technologies Q1 Earnings Call Highlights

UFP Technologies (NASDAQ:UFPT) reported first-quarter 2026 results that management said reflected a solid start to the year, led by continued growth in its medical business and progress on strategic...

UFP Technologies (NASDAQ:UFPT) Shares Gap Down   - Time to Sell?

UFP Technologies (NASDAQ:UFPT) Shares Gap Down - Here's Why...

UFP Technologies (UFPT) Tops Q1 Earnings Estimates

UFP (UFPT) delivered earnings and revenue surprises of +13.76% and -2.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

UFP Technologies (NASDAQ:UFPT) Issues Earnings Results

UFP Technologies (NASDAQ:UFPT - Get Free Report) announced its quarterly earnings data on Monday. The industrial products company reported $2.48 earnings per share (EPS) for the quarter, beating...

UFP Technologies Announces Strong Q1 Results

UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.5...

UFP Technologies, Inc. engages in designing and custom manufacturing of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics primarily for the medical market. The firm manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding and fabricating manufacturing techniques. Its products include military uniform and gear components, automotive interior trim, athletic padding, environmentally friendly protective packaging, air filtration, abrasive nail files, and protective cases and inserts. The company was founded by Richard L. Bailly, Robert W. Drew, Sr. and William H. Shaw in 1963 and is headquartered in Newburyport, MA.

UFP Technologies Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$2.31	--	--	N/A
Q1 '26	$2.14	$2.24	4.80%	BEAT
Q4 '25	$2.07	$2.25	8.79%	BEAT
Q3 '25	$2.17	$2.11	-2.88%	MISSED
Q2 '25	$2.25	$2.50	11.11%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

UFPTUFP Technologies Inc.

Upcoming Earnings: Q2 '26

Historical Earnings

Latest UFPT News